Trasylol Kidney Failure Side Effects
Bayer’s Trasylol problems continuing to grow following new studies showing the drug’s side effects. Trasylol has recently been linked to a higher risk of kidney failure, heart attacks, and death in the five years following a patient undergoing bypass heart surgery. Trasylol (Aprotinin) was approved by the Federal Drug Administration in 1993. Aprotinin is manufactured by Bayer under the brand name Trasylol. Over the past several years Trasylol sales had continued to increase until it was pulled from the market late in 2007. Prior to being removed from the market the drug had been in use for 13 years and over a million heart surgery patients had received it.
Most heart surgery patients don’t know if they were given Trasylol during their open heart surgery. Many patients suffering from Trasylol kidney failure side effects don’t know if they were given Trasylol during their surgery because the surgeon made the decision whether to administer the drug to help reduce excessive bleeding during surgery.
Trasylol affects the way in which blood clots. It is given to open bypass surgery patients to prevent excessive bleeding. Trasylol is mainly used during repeat coronary artery bypass surgery to reduce the amount of bleeding both during and after surgery. One of the most serious complications for bypass surgery patients is excessive bleeding. Clotting medications such as Trasylol reduce the amount of blood transfusion needed during surgery. In 2006 The New England Journal of Medicine (NEJM) published a study that reported Trasylol problems with an increased risk of developing heart failure, kidney damage, myocardial infarction, and stroke in bypass heart surgery patients.
We are a Law Firm that is dedicated to helping people who have been affected by Trasylol side effects.
Personal Injury Law Firm
- Trasylol Lawsuit News | Aprotinin Heart Surgery Drugs Renal Failure
- Surgery Trasylol Law Suit News | Trasylol Lawyer
- Trasylol Lawsuits | Trasylol Bayer News
- Aprotinin Drug Trasylol | Class Action Lawsuit
- Class Action Trasylol Updates | Heart Surgery Drug
- Trasylol Side Effects | Trasylol Litigation News
- Trasylol Lawsuit News | Trasylol Recall
Bayer HealthCare Pharmaceuticals, Inc. has been facing an increasing number of patients who have filed a Trasylol lawsuit over its Aprotinin heart surgery drug. The lawsuits allege that Bayer is liable for manufacturing and failing to warn Trasylol users of its dangerous side effects. The Trasylol lawsuits allege that Bayer knew Trasylol increases patients’ risk [...]
Until recently, Bayer’s anti-bleeding drug was used on a regular basis during heart surgery. Trasylol (Aprotinin) is widely used to decrease bleeding risk during coronary artery bypass graft (CABG) surgery. There are some common side effects that persist or become bothersome following use, including: constipation, diarrhea, difficulty urinating, infection (fever, chills, sore throat), lightheadedness, sleeplessness [...]
We represent all Trasylol lawsuits clients on a contingency basis which means that there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please call toll free at 1-888-343-5375 or fill out our short online contact form and a Trasylol lawyer will contact you to answer any of [...]
Trasylol Aprotinin Side Effects Study
Another study reveals an increased risk of serious Trasylol side effects leading to a higher mortality rate in aprotinin bypass patients. A recent study published in The New England Journal of Medicine on February 21, 2008 shows an increased risk of death for patients receiving aprotinin (Trasylol) during coronary-artery bypass grafting [...]
Trasylol Heart Surgery Drug Information
What is aprotinin injection?
APROTININ (Trasylol) is a drug that affects the way blood clots. It was given to heart surgery patients during bypass procedures. Aprotinin was mainly used during repeat coronary artery bypass surgery to reduce the amount of bleeding before and after surgery. Trasylol and other clotting medications help to [...]
